-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Severity.PDF
January 01, 2008 - .**%
4560: SP FUS EXC CERV W CURV/MAL/INF/9+ WO C/M 1,478 0.02%
4561: SP FUS EXC CERV W CURV/MAL/INF … /NON-MAL AGE>17 W MCC 2,153 0.03%
7424: UTER&ADNX PX/NON-MAL 0-17 WO CC/MC 191 0.00%
7425: UTER&ADNX … PX/NON-MAL 0-17 W CC 38 0.00%
7426: UTER&ADNX PX/NON-MAL 0-017 W MCC <= 10 *.**%
7430: LPSCP,ENDSCP … /PRLY DIF NEO MAJ OR PX W MCC 428 0.01%
8290: MYLPRLF DIS/PRLY DIF NEO OTH OR WO CC/MC 386 0.00%
8291 … : MYLPRLF DIS/PRLY DIF NEO OTH OR W CC 575 0.01%
8292: MYLPRLF DIS/PRLY DIF NEO OTH OR W MCC 275 0.00%
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Severity.PDF
January 01, 2009 - /NON-MAL AGE>17 W MCC 2,039 0.03%
7424: UTER&ADNX PX/NON-MAL 0-17 WO CC/MC 606 0.01%
7425: UTER&ADNX … PX/NON-MAL 0-17 W CC 147 0.00%
7426: UTER&ADNX PX/NON-MAL 0-017 W MCC 46 0.00%
7430: LPSCP,ENDSCP, … MAJ OR WO CC/MC 559 0.01%
8261: MYLPRLF DIS/PRLY DIF NEO MAJ OR PX W CC 891 0.01%
8262: MYLPRLF DIS … /PRLY DIF NEO MAJ OR PX W MCC 395 0.01%
8290: MYLPRLF DIS/PRLY DIF NEO OTH OR WO CC/MC 338 0.00%
8291 … : MYLPRLF DIS/PRLY DIF NEO OTH OR W CC 563 0.01%
8292: MYLPRLF DIS/PRLY DIF NEO OTH OR W MCC 309 0.00%
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsDefManualV25Public.pdf
June 01, 2009 - 455 453 COMB ANT/POST SPIN FUS
456 456 SP FUS EXC CERV W CURV/MAL … /INF/9+
457 456 SP FUS EXC CERV W CURV/MAL/INF/9+
458 456 SP FUS EXC CERV W CURV … /MAL/INF/9+
459 459 SPIN FUS EXC CERV
460 459 SPIN FUS EXC CERV … MAJ OR PX
827 826 MYLPRLF DIS/PRLY DIF NEO MAJ OR PX
828 826 MYLPRLF DIS/PRLY … DIF NEO MAJ OR PX
829 829 MYLPRLF DIS/PRLY DIF NEO OTH OR
830 829 MYLPRLF DIS/PRLY
-
hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2019-1.pdf
September 01, 2019 - chapters) Three Character
Abbreviation
Certain infectious and parasitic diseases INF
Neoplasms NEO … Categories
CCS
Categories
(Beta
Versions)
INF Certain infectious and parasitic diseases 11 10
NEO … childbirth and the puerperium 30 21
PNL Certain conditions originating in the perinatal period 13 7
MAL … infectious and parasitic diseases (INF) – fungal infections; foodborne
intoxications
• Neoplasms (NEO … digestive and feeding disorders
• Congenital malformations, deformations, and chromosomal abnormalities (MAL
-
hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-User-Guide-v2025-1.pdf
November 01, 2024 - Congenital malformations, deformations and
chromosomal abnormalities MAL
MAL contains 10 categories … Neoplasms NEO
NEO contains 78 categories specific to
neoplasms, which include malignant neoplasms … effects, initial encounter
• Congenital malformations, deformations, and chromosomal abnormalities (MAL … and connective tissue (MUS) – scoliosis and
other postural dorsopathic deformities
• Neoplasms (NEO … Body System
Abbreviation
Certain infectious and parasitic diseases A00–B99 INF
Neoplasms C00–D49 NEO
-
datatools.ahrq.gov/hcupnet/methodology/
January 01, 2023 - the ICD-10-CM diagnosis chapters:
Certain Infectious and Parasitic Diseases (INF)
Neoplasms (NEO … the Perinatal Period (PNL)
Congenital Malformations, Deformations and Chromosomal Abnormalities (MAL
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/3XUeA-_n8KhYeS95ohoo2_
August 03, 2020 - of women with high he¬
moglobin levels, but it occurred in only
5% and 4% of women with low and nor¬
mal … evidence) of iron supplemen¬
tation have not demonstrated signifi¬
cant improvements in maternal or neo … Biol Neo-
nate. 1991;60:303-307.
50. Oski FA. Iron deficiency: facts and fallacies.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/7eLc5kBtomL_HKpYDwsFPf
July 01, 2009 - One cohort study found that after a nor-
mal baseline eye examination, the likelihood of experienc-
ing … Verteporfin therapy for subfoveal choroidal neo-
vascularization in age-related macular degeneration: … Randomized, double-masked, sham-controlled trial of ranibizumab for neo-
vascular age-related macular … Photocoagulation
Study Group, 1991 (54)
To determine the
effect on vision of
laser treatment of
subfoveal neo
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
March 08, 2012 - P-Tann or Allerlief or Chlor-Al Rel or Myci Chlorped or Pediatan or
Ahist or Aller-Chlor or Chlor-Mal … Afrin or
(Allerest adj3 Nasal) or Dristan or Duramist plus or Four-Way or Mucinex Nasal or Nasin or
Neo-Synephrine
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2018.pdf
January 01, 2018 - External Causes 892,062 11.60% 4,853,684 63.09%
InvlDX: Invalid diagnosis 243 0.00% 4,853,927 63.09%
MAL … MUS: Diseases of the Musculoskeletal System and Connective Tissue 1,185,024 15.40% 6,141,405 79.83%
NEO
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2018.pdf
January 01, 2018 - External Causes 1,246,815 11.66% 6,773,310 63.32%
InvlDX: Invalid diagnosis 325 0.00% 6,773,635 63.33%
MAL … MUS: Diseases of the Musculoskeletal System and Connective Tissue 1,654,039 15.46% 8,566,406 80.09%
NEO
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2018_DX_PR_GRPS_MaskedStats.PDF
January 01, 2018 - Certain Other Consequences of External Causes 6,626,929 18.51
InvlDX: Invalid diagnosis 889 0.00
MAL … Disorders 1,606,116 4.49
MUS: Diseases of the Musculoskeletal System and Connective Tissue 2,523,363 7.05
NEO
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2018_DX_PR_GRPS.PDF
January 01, 2018 - and Certain Other Consequences of External Causes 547,124 7.70%
InvlDX: Invalid diagnosis 182 0.00%
MAL … Disorders 398,574 5.61%
MUS: Diseases of the Musculoskeletal System and Connective Tissue 435,572 6.13%
NEO
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_DX_PR_GRPS.PDF
January 01, 2018 - Certain Other Consequences of External Causes 1,439,180 8.14%
InvlDX: Invalid diagnosis 164 0.00%
MAL … 1,044,120 5.90%
MUS: Diseases of the Musculoskeletal System and Connective Tissue 1,196,977 6.77%
NEO